Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.34
-0.34-9.24%
At close: Jan 16, 4:00 PM EST
$3.39
0.051.50%
After Hours: Jan 16, 7:47 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Agenus (AGEN) stock?
You can purchase shares of Agenus (NASDAQ:AGEN) through any online brokerage.
Who are Agenus (AGEN) competitors?
Other companies in Agenus’s space includes: Tharimmune Inc (NASDAQ:THAR), Connect Biopharma Holdings Ltd (NASDAQ:CNTB), Elicio Therapeutics Inc (NASDAQ:ELTX), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Fate Therapeutics Inc (NASDAQ:FATE).
What is the forecast, or price target, for Agenus (AGEN) stock?
Agenus has a consensus price target of $11.23.
What is the current price for Agenus (AGEN)?
The stock price for Agenus (NASDAQ: AGEN) is $3.39 last updated January 16, 2026 at 7:47 PM EST.
Does Agenus (AGEN) pay a dividend?
There are no upcoming dividends for Agenus.
When is Agenus (NASDAQ:AGEN) reporting earnings?
Agenus does not have any upcoming earnings scheduled.
Is Agenus (AGEN) going to split?
There is no upcoming split for Agenus.
What sector and industry does Agenus (AGEN) operate in?
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
